Invention Grant
- Patent Title: Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
-
Application No.: US15377662Application Date: 2016-12-13
-
Publication No.: US09987253B2Publication Date: 2018-06-05
- Inventor: John F McElroy , Robert J Chorvat
- Applicant: Jenrin Discovery
- Applicant Address: US DE Wilmington
- Assignee: JENRIN DISCOVERY, INC.
- Current Assignee: JENRIN DISCOVERY, INC.
- Current Assignee Address: US DE Wilmington
- Agency: Vance Intellectual Property, PC
- Main IPC: A61K31/415
- IPC: A61K31/415 ; C07D231/06
Abstract:
The present invention provides novel, diastereomeric pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.
Public/Granted literature
Information query
